XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Using Index Funds In Retirement Portfolios discusses straightforward methods to blend broad-market index funds into retirement allocations.
18,590 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
A long-stalled crypto bill in Congress shows little traction after Trump’s social media post. TD Cowen notes that pre...
These software stocks have surged as geopolitical tensions rise, outpacing broader tech gains and signaling a shift i...
The Dow rose above a key threshold—49,683.30—on Thursday, putting it on a path to officially exit correction territor...
A high-profile hedge fund billionaire made bold moves, piling into Amazon and Microsoft while slashing a top AI stock...
The latest BEA data show the Fed's preferred inflation measure at a three-year high, signaling price pressures may pe...
The Nasdaq Composite climbed again as semiconductors rebound and AI-driven demand steadies, signaling a renewed risk-...
Chip stocks setting records kept up the rally as AI demand supports semiconductors, but a cooling RSI and a hidden be...
S&P Global recently completed a strategic spin-off, triggering a near 8% jump in the parent stock. Here’s what happen...
Chip-led gains lift the Nasdaq Composite as chipmakers regain leadership, while software names soften amid mixed dema...
Markets wobble as investors weigh ongoing AI-driven growth against macro and policy risks, highlighting wall street’s...
Over five years, SPDR’s XLK delivered a 35-point edge on the S&P 500, even as a Feb 2026 pullback tested investor ner...